Medical Microbiology and Immunology

, Volume 201, Issue 3, pp 259–269

Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort

  • Glenn Lawyer
  • Eugen Schülter
  • Rolf Kaiser
  • Stefan Reuter
  • Mark Oette
  • Thomas Lengauer
  • The RESINA Study Group
Original Investigation


HIV’s genetic instability means that sequence similarity can illuminate the underlying transmission network. Previous application of such methods to samples from the United Kingdom has suggested that as many as 86% of UK infections arose outside of the country, a conclusion contrary to usual patterns of disease spread. We investigated transmission networks in the Resina cohort, a 2,747 member sample from Nordrhein-Westfalen, Germany, sequenced at therapy start. Transmission networks were determined by thresholding the pairwise genetic distance in the pol gene at 96.8% identity. At first blush the results concurred with the UK studies. Closer examination revealed four large and growing transmission networks that encompassed all major transmission groups. One of these formed a supercluster containing 71% of the sex with men (MSM) subjects when the network was thresholded at levels roughly equivalent to those used in the UK studies, though methodological differences suggest that this threshold may be too generous in the current data. Examination of the endo- versus exogenesis hypothesis by testing whether infections that were exogenous to Cologne or to Dusseldorf were endogenous to the greater region supported endogenous spread in MSM subjects and exogenous spread in the endemic transmission group. In intravenous drug using group subjects, it depended on viral strain, with subtype B sequences appearing to have origin exogenous to the Resina data, while non-B sequences (primarily subtype A) were almost completely endogenous to their local community. These results suggest that, at least in Germany, the question of endogenous versus exogenous linkages depends on subject group.


Transmission network Network epidemiology Disease spread Endogenous 


  1. 1.
    Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, Holmes EC (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303(5656):327–332. doi:10.1126/science.1090727 Google Scholar
  2. 2.
    Pybus OG, Rambaut A (2009) Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10(8):540–550. doi:10.1038/nrg2583 Google Scholar
  3. 3.
    Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK (1994) The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 330(24):1703–1709. doi:10.1056/NEJM199406163302402
  4. 4.
    Salathé M, Jones JH (2010) Dynamics and control of diseases in networks with community structure. PLoS Comput Biol 6(4):e1000,736. doi:10.1371/journal.pcbi.1000736
  5. 5.
    Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA, Group QPHIS (2007) High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 195(7):951–959PubMedCrossRefGoogle Scholar
  6. 6.
    Brenner BG, Roger M, Moisi DD, Oliveira M, Hardy I, Turgel R, Charest H, Routy JP, Wainberg MA, Cohort MP, Groups HIVPS (2008) Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 22(18):2509–2515. doi:10.1097/QAD.0b013e3283121c90 Google Scholar
  7. 7.
    Castro E, Khonkarly M, Ciuffreda D, Bürgisser P, Cavassini M, Yerly S, Pantaleo G, Bart PA (2010) HIV-1 drug resistance transmission networks in southwest Switzerland. AIDS Res Hum Retroviruses 26(11):1233–1238. doi:10.1089/aid.2010.0083 Google Scholar
  8. 8.
    Hué S, Pillay D, Clewley JP, Pybus OG (2005) Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci USA 102(12):4425–4429. doi:10.1073/pnas.0407534102 Google Scholar
  9. 9.
    Lewis F, Hughes GJ, Rambaut A, Pozniak A, Brown AJL (2008) Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5(3):e50. doi:10.1371/journal.pmed.0050050
  10. 10.
    Hughes GJ, Fearnhill E, Dunn D, Lycett SJ, Rambaut A, Brown AJL, U.K.HIV Drug Resistance Collaboration (2009) Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 5(9):e1000,590Google Scholar
  11. 11.
    Mumtaz G, Hilmi N, Akala FA, Semini I, Riedner G, Wilson D, Abu-Raddad LJ (2011) HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa. Sex Transm Infect 87(2):101–106. doi:10.1136/sti.2010.043711 Google Scholar
  12. 12.
    Volz E, Frost SDW, Rothenberg R, Meyers LA (2010) Epidemiological bridging by injection drug use drives an early HIV epidemic. Epidemics 2(3):155–164. doi:10.1016/j.epidem.2010.06.003 Google Scholar
  13. 13.
    Biek R, Real LA (2010) The landscape genetics of infectious disease emergence and spread. Mol Ecol 19(17):3515–3531. doi:10.1111/j.1365-294X.2010.04679.x Google Scholar
  14. 14.
    Helsley RW, Zenou Y (2011) Social networks and interactions in cities. SSRN eLibraryGoogle Scholar
  15. 15.
    R.E.S.I.N.A. Study Team: (2007) Trends of prevalence of primary HIV drug resistance in Germany. J Antimicrob Chemother 60(4):843–848PubMedCrossRefGoogle Scholar
  16. 16.
    Oette M, Kaiser R, Däumer M, Akbari D, Fätkenheuer G, Rockstroh JK, Stechel J, Rieke A, Mauss S, Schmalöer D, Göbels K, Vogt C, Wettstein M, Häussinger D (2004) Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany. Eur J Med Res 9(5):273–278PubMedGoogle Scholar
  17. 17.
    Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J, Kadie C, Bhattacharya T, Chui C, Szinger J, Mo T, Hogg RS, Montaner JSG, Frahm N, Brander C, Walker BD, Harrigan PR (2007) Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 3(7):e94. doi:10.1371/journal.ppat.0030094
  18. 18.
    Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31(1):298–303PubMedCrossRefGoogle Scholar
  19. 19.
    Center for Disease Control and Prevention (2005) HIV prevelance, unrecognized infection, and HIV testing among men who have sex with men–five U.S. cities, June 2004–April 2005. Morb Mortal Wkly Rep 54. U.S. Department of Health and Human Services, Center for Disease Control and PreventionGoogle Scholar
  20. 20.
    Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73(12):10,489–10,502Google Scholar
  21. 21.
    Schülter E, Oette M, Balduin M, Reuter S, Rockstroh J, Fätkenheuer G, Esser S, Lengauer T, Agacfidan A, Pfister H, Kaiser R, Akgül B (2011) HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany. Med Microbiol Immunol. doi:10.1007/s00430-011-0193-2

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Glenn Lawyer
    • 1
  • Eugen Schülter
    • 2
  • Rolf Kaiser
    • 2
  • Stefan Reuter
    • 3
  • Mark Oette
    • 4
  • Thomas Lengauer
    • 1
  • The RESINA Study Group
  1. 1.Department of Computational BiologyMax Planck Institute for InformaticsSaarbrückenGermany
  2. 2.Institute of VirologyUniversity of CologneCologneGermany
  3. 3.Clinic for Gastroenterology, Hepatology and Infectious DiseasesUniversity HospitalDüsseldorfGermany
  4. 4.Clinic for General Medicine, Gastroenterology and Infectious DiseasesAugustinerinnen HospitalCologneGermany

Personalised recommendations